Blue Earth Therapeutics will leverage SHINE’s non-carrier added lutetium-177 chloride, Ilumira, in a new treatment for prostate cancer undergoing clinical trials JANESVILLE, Wis., June 6, 2024 /PRNewswire/ — SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative […]